Daily non-political popular news in brief.

Diuretics excel in drug comparison trial involving hypertension/metabolic syndrome

Diuretics were associated with reduced heart disease in a drug comparison trial involving 23,077 people with both high blood pressure and the metabolic syndrome, a cluster of risk factors for heart disease, report researchers from the University of Texas School of Public Health and Case Western Reserve University in the Jan. 28 issue of the Archives of Internal Medicine, one of the JAMA/Archives journals.

Read more »

Keywords: diuretics, excel, drug, comparison, trial, involving, hypertension, metabolic, syndrome, diuretic

« Previous | Next »

Similar news on "Diuretics excel in drug comparison trial involving hypertension/metabolic syndrome":

1. Diuretics comparable to or better than other hypertension drugs in patients with metabolic syndrome
   01-28-2008 · EurekAlert!
   Use of calcium-channel blockers, alpha-blockers or angiotensin-converting enzyme inhibitors appears to offer no advantages in improving clinical outcomes compared with use of diuretics when treating hypertension among individuals with metabolic syndrome, according to a report in the Jan. 28 issue of Archives of Internal Medicine, one of the JAMA/Archives journals. This appears particularly true for black patients.
   Similar news · Read more »
   
2. New treatment increases life time expectancy of patients suffering from advanced liver cancer
   06-04-2007 · EurekAlert!
   A clinical trial led and coordinated by Hospital Clínic-IDIBAPS, using a drug named Sorafenib, revolutionizes the reality of patients suffering from advanced liver cancer. The results increase overall survival of treated patients by 44 percent in comparison to the control group. The results have been hand selected to be included on the "Best of ASCO" program.
   Similar news · Read more »
   
3. Common cause of heart disease, diabetes may be treatable with malaria drug
   11-07-2006 · EurekAlert!
   Studies of a rare genetic condition that increases cancer risk have unveiled a potential treatment for metabolic syndrome, a common disorder that afflicts as many as one in every four American adults and puts them at sharply increased risk of type 2 diabetes and clogged arteries.
   Similar news · Read more »
   
4. Story ideas from the Journal of Lipid Research
   01-10-2008 · EurekAlert!
   Metabolic syndrome, a collection of related abnormalities like hypertension, obesity, insulin resistance, and excess cholesterol, poses a major risk for developing heart disease and diabetes. Individuals with a genetic predisposition to high cholesterol can be especially vulnerable to metabolic syndrome, but researchers have now found that blocking the enzyme stearoyl-CoA desaturase-1, which helps synthesize unsaturated fatty acids, greatly improves the profile of FH-mice affected by metabolic syndrome.
   Similar news · Read more »
   
5. Pediatricians call for a cohesive definition of metabolic syndrome in children
   01-10-2008 · EurekAlert!
   Metabolic syndrome is a group of cardiovascular risk factors, including obesity, hypertension, prediabetes, and reduced HDL ("good") cholesterol. Because it is difficult to know when a child is at risk for metabolic syndrome, some doctors fear that children may not be properly diagnosed as a result. The February 2008 issue of The Journal of Pediatrics focuses on this issue by publishing a series of articles in an attempt to work toward a cohesive definition of metabolic syndrome in children.
   Similar news · Read more »
   
6. Major breakthrough toward the treatment of HIV/HAART-associated Lipodystrophy Syndrome
   12-05-2007 · EurekAlert!
   The HIV/HAART-associated Lipodystrophy Syndrome is a common side-effect of antiretroviral medications to treat HIV infection. Dr. Julian Falutz, director of the HIV Metabolic Clinic at the McGill University Health Center, and Dr. Steven Grinspoon, director at the Massachusetts General Hospital Program in nutritional metabolism are publishing the results of their recent clinical trial in the Dec. 6, 2007, issue of the New England Journal of Medicine.
   Similar news · Read more »
   
7. New drug reduces abdominal fat accumulation and improves lipids in HIV-infected patients
   12-05-2007 · EurekAlert!
   Treatment with an investigational drug that induces the release of growth hormone significantly improved the symptoms of HIV lipodystrophy, a condition involving the redistribution of fat and other metabolic changes in patients receiving combination drug therapy for HIV infection.
   Similar news · Read more »
   
8. Hormone therapy does not improve quality of life for women
   11-06-2006 · EurekAlert!
   A postmenopausal hormone therapy trial conducted in Estonia indicates that hormone therapy does not improve women's quality of life. The group receiving hormones and the comparison group showed no differences in general quality of life. Only those women that experienced hot flashes and night-time sweating reported beneficial effects.
   Similar news · Read more »
   
9. New drug helps hepatitis C patients start antiviral therapy
   10-30-2006 · EurekAlert!
   A new drug that stimulates the production of blood platelets can enable patients infected with hepatitis C virus to take other antiviral medications they previously could not take to fight the disease, according to the results of a clinical trial led by a Duke University Medical Center researcher.
   Similar news · Read more »
   
10. Drug that chokes off tumor blood vessels offers new hope to lung cancer patients
    12-13-2006 · EurekAlert!
    Patients suffering from the most common type of lung cancer experienced a 20-percent improvement in overall survival in a national clinical trial of a drug that chokes off the blood vessels nourishing tumors, a multicenter study has found.
    Similar news · Read more »